Quality of Life After Cytoreductive Surgery and Intraperitoneal Chemotherapy

Recovery of Quality of Life After Cytoreductive Surgery and Intraperitoneal Chemotherapy for Colorectal Cancer and Pseudomyxoma Peritonei

Cytoreductive surgery with intraperitoneal chemotherapy is one of the most important treatments for patients with colorectal cancer and peritoneal metastasis. For the best survival rates, complete removal of all metastatic lesions is the most important part of treatment, and various surgical procedures are required for the complete cytoreduction. Therefore, the postoperative morbidity rates are higher than those of localized colon cancer surgeries and patients can experience a prolonged recovery period and deterioration of physical activities over a long period. The aim of this study is to investigate the change of quality of life after cytoreductive surgery and intraperitoneal chemotherapy for colorectal cancer.

Inclusion Criteria:

• Colorectal cancer peritoneal metastasis
• Pseudomyxoma peritonei
• ECOG (Eastern Cooperative Oncology Group) performance status 0-3
• Normal bone marrow, kidney, and liver function
• Patient must sign and date the informed consent

Exclusion Criteria:

• Palliative surgery
• Palliative intraperitoneal chemotherapy
• Psychotic disorder
• Drug abuser